Dr. Reddy's Laboratories Limited Stock Analysis

Dr. Reddy's Laboratories Limited is a leading integrated pharmaceutical company operating globally. It manufactures and markets a wide range of pharmaceutical products and active ingredients. The company has a strong presence in the healthcare sector and is known for its innovative therapies and digital healthcare services.

Key Financial Statistics

• Current Price: INR 5730.8
• Market Cap: 954,464,731,136
• Dividend Yield: 0.0069
• 52 Week High: 6505.9
• 52 Week Low: 4605.0

Company Officers

Dr. Reddy's Laboratories Limited is led by a team of experienced and accomplished individuals who hold key positions in the company. The leadership team includes Mr. Gunupati Venkateswara Prasad, Mr. Kallam Satish Reddy, Mr. Erez Israeli, Mr. Parag Agarwal, and others.

Key Ratios and Margins

• Profit Margins: 19.947%
• Return on Assets: 11.667%
• Debt to Equity: 7.136
• Operating Margins: 20.875%

Analyst Recommendations

• Target High Price: 7500.0
• Target Low Price: 4245.0
• Recommendation: Hold
• Number of Analyst Opinions: 34

Conclusion

Dr. Reddy's Laboratories Limited shows strong financial performance, a competent leadership team, and positive analyst recommendations. The company's innovative approach to healthcare and solid market presence make it an attractive investment option in the pharmaceutical industry.